Home Blog Page 2
Enhancements include upgrading the platform’s sponsor-reviewer interaction, adding support for multi-omics, and offering a library of analytical, statistical, and machine learning applications that are both accessible to reviewers and sufficiently powerful for bioinformaticians.
Meeting handshake
The company will initially use the FDA-cleared, automated nCounter system which can simultaneously analyze RNA, DNA or protein targets in up to 800 genes, for uses in diopathic pulmonary fibrosis diagnosis and breast cancer diagnosis.
John Halamka, M.D., will oversee Mayo Clinic Platform as it carries out initial projects focused on home healthcare scheduling, patient data uploading, and supplying patient-specific treatment information based on Mayo Clinic data.
Colon cancer. Cancer attacking cell. Colon disease concept
The researchers used a Cancer rainbow (Crainbow) modeling system for fluorescently barcoding somatic mutations to directly visualize the clonal expansion and spread of oncogenes.
Researchers scanned 5,000 proteins in single blood plasma samples taken from 16,894 participants to simultaneously capture the individualized imprints of current health status, and incident risk of cardiometabolic diseases such as diabetes, coronary heart disease, stroke,and heart failure.
QFT-Plus is designed to offer streamlined laboratory automation for latent TB screening, supporting conversion from century-old tuberculin skin tests to fourth-generation blood-based QuantiFERON technology.
The genetic testing and associated services will help the 13,800 Fund members better understand their genetic risk for hereditary cancers, heart disease, and medication response.
The collaboration is intended to enhance Indivumed’s database by adding proteome-level data from thousands of samples using Biognosys’ proteomics technology, with the goal of enabling discoveries in cancer biology.
Researchers compared the genomes of four hibernating mammals with humans to search for genetic links modulating hibernation, obesity and metabolic disorders and identified 364 potential genetic elements they believe could have a role in regulating hibernation and obesity.
Genomenon said today it has partnered with Rhythm Pharmaceuticals to create a database of genetic mutations associated with obesity as documented in published studies. Rhythm plans to use the data to better understand rare genetic disorders of obesity. [Visual Mozart/Getty Images]
Digbi Health gives Blue Shield members access to a DNA- and gut microbiome-based precision care and personalized lifestyle medicine tool that is tailored to their unique biologies and lifestyles.
Scroll Up